International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8055004
Original Article
Early Onset Septicemia in Term Neonates: Corelation Between Sepsis, Maternal and Neonatal Risk Factors and Clinical Profile
 ,
 ,
Published
June 19, 2023
Abstract
Neonatal sepsis is a clinical syndrome of bacteremia characterized by systemic signs and symptoms of infection in the first month of life. Neonatal sepsis encompasses systemic infection of the new born including septicemia, meningitis, pneumonia, arthritis, osteomyelitis and urinary tract infection of newborn [AIIMS] [1]. A prospective nonrandomised study was conducted in neonatal intensive care unit. At risk babies were further evaluated and investigations like complete blood count, C reactive protein, chest xray, body fluid examination( cerebrospinal fluid and urine ) and blood culture was sent. Then according to the clinical presentation and the investigations reports, antibiotic pattern was decided. Majority of the neonates had hypothermia as the presenting clinical feature followed by respiratory distress and poor perfussion. Hypothermia was the most common clinical feature steps can be taken to minimise hypothermia by proper maintenance of warm chain and early initiation of breast feeding .Higher incidence of septicemia is seen in male patients as compared to female patients. Early identification of the presenting feature and early initiation of antibiotics can play a major contributing role in reducing mortality and complications of early onset septicemia. Practicing and maintain aspetic precautions from the place of delivery and in the neonatal intensive care unit can also reduce the incidence of early onset septicemia.[Nelson][2]
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
414 Views
168 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved